全文获取类型
收费全文 | 773篇 |
免费 | 193篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 28篇 |
妇产科学 | 62篇 |
基础医学 | 63篇 |
口腔科学 | 11篇 |
临床医学 | 252篇 |
内科学 | 174篇 |
皮肤病学 | 12篇 |
神经病学 | 36篇 |
特种医学 | 24篇 |
外科学 | 90篇 |
综合类 | 5篇 |
预防医学 | 86篇 |
眼科学 | 17篇 |
药学 | 35篇 |
中国医学 | 4篇 |
肿瘤学 | 63篇 |
出版年
2024年 | 3篇 |
2023年 | 31篇 |
2022年 | 23篇 |
2021年 | 37篇 |
2020年 | 29篇 |
2019年 | 18篇 |
2018年 | 47篇 |
2017年 | 50篇 |
2016年 | 50篇 |
2015年 | 52篇 |
2014年 | 66篇 |
2013年 | 66篇 |
2012年 | 45篇 |
2011年 | 43篇 |
2010年 | 34篇 |
2009年 | 56篇 |
2008年 | 32篇 |
2007年 | 31篇 |
2006年 | 36篇 |
2005年 | 16篇 |
2004年 | 26篇 |
2003年 | 15篇 |
2002年 | 17篇 |
2001年 | 12篇 |
2000年 | 6篇 |
1999年 | 13篇 |
1998年 | 17篇 |
1997年 | 21篇 |
1996年 | 13篇 |
1995年 | 8篇 |
1994年 | 4篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1986年 | 5篇 |
1985年 | 2篇 |
1980年 | 3篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1972年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1968年 | 2篇 |
1966年 | 1篇 |
1958年 | 1篇 |
排序方式: 共有969条查询结果,搜索用时 15 毫秒
861.
Mateo Anson N Aura AM Selinheimo E Mattila I Poutanen K van den Berg R Havenaar R Bast A Haenen GR 《The Journal of nutrition》2011,141(1):137-143
Whole grain consumption has been linked to a lower risk of metabolic syndrome, which is normally associated with a low-grade chronic inflammation. The benefits of whole grain are in part related to the inclusion of the bran, rich in phenolic acids and fiber. However, the phenols are poorly bioaccessible from the cereal matrix. The aim of the present study was to investigate the effect of bioprocessing of the bran in whole wheat bread on the bioavailability of phenolic acids, the postprandial plasma antioxidant capacity, and ex vivo antiinflammatory properties. After consumption of a low phenolic acid diet for 3 d and overnight fasting, 8 healthy men consumed 300 g of whole wheat bread containing native bran (control bread) or bioprocessed bran (bioprocessed bread) in a cross-over design. Urine and blood samples were collected for 24 h to analyze the phenolic acids and metabolites. Trolox equivalent antioxidant capacity was measured in plasma. Cytokines were measured in blood after ex vivo stimulation with LPS. The bioavailabilities of ferulic acid, vanillic acid, sinapic acid, and 3,4-dimethoxybenzoic acid from the bioprocessed bread were 2- to 3-fold those from the control bread. Phenylpropionic acid and 3-hydroxyphenylpropionic acid were the main colonic metabolites of the nonbioaccessible phenols. The ratios of pro-:antiinflammatory cytokines were significantly lower in LPS-stimulated blood after the consumption of the bioprocessed bread. In conclusion, bioprocessing can remarkably increase the bioavailability of phenolic acids and their circulating metabolites, compounds which have immunomodulatory effects ex vivo. 相似文献
862.
863.
Pinto-Leite R Arantes-Rodrigues R Palmeira C Gaivão I Cardoso ML Colaço A Santos L Oliveira P 《Journal of toxicology and environmental health. Part A》2012,75(13-15):788-799
The purpose of this study was to determine whether everolimus, a rapamycin derivative, might significantly enhance the cytotoxicity of gemcitabine, an antitumor drug, in two human bladder-cancer cell lines. Human bladder-cancer T24 and 5637 cells were incubated with gemcitabine and everolimus in a range of concentrations either alone or in combination for 72 h. Flow cytometry, comet assay, MTT method and optical microscopy were used to assess cell proliferation, cell cycle, DNA damage, and morphological alterations. Gemcitabine exerted an inhibitory effect on T24 and 5637 cell proliferation, in a concentration-dependent manner. Everolimus significantly reduced proliferation of 5637 bladder cancer cells (IC??) at 1 μM), whereas T24 demonstrated marked resistance to everolimus treatment. A significant antiproliferative effect was obtained combining gemcitabine (100 nM) with everolimus (0.05-2 μM) with an arrest of cell cycle at S phase. Furthermore, an increase in frequency of DNA damage, apoptotic bodies, and apoptotic cells was observed when T24 and 5637 cancer cells were treated simultaneously with both drugs. Data show that in vitro combination produced a more potent antiproliferative effect when compared with single drugs. 相似文献
864.
865.
866.
Scaltriti M Eichhorn PJ Cortés J Prudkin L Aura C Jiménez J Chandarlapaty S Serra V Prat A Ibrahim YH Guzmán M Gili M Rodríguez O Rodríguez S Pérez J Green SR Mai S Rosen N Hudis C Baselga J 《Proceedings of the National Academy of Sciences of the United States of America》2011,108(9):3761-3766
Clinical benefits from trastuzumab and other anti-HER2 therapies in patients with HER2 amplified breast cancer remain limited by primary or acquired resistance. To identify potential mechanisms of resistance, we established trastuzumab-resistant HER2 amplified breast cancer cells by chronic exposure to trastuzumab treatment. Genomewide copy-number variation analyses of the resistant cells compared with parental cells revealed a focal amplification of genomic DNA containing the cyclin E gene. In a cohort of 34 HER2(+) patients treated with trastuzumab-based therapy, we found that cyclin E amplification/overexpression was associated with a worse clinical benefit (33.3% compared with 87.5%, P < 0.02) and a lower progression-free survival (6 mo vs. 14 mo, P < 0.002) compared with nonoverexpressing cyclin E tumors. To dissect the potential role of cyclin E in trastuzumab resistance, we studied the effects of cyclin E overexpression and cyclin E suppression. Cyclin E overexpression resulted in resistance to trastuzumab both in vitro and in vivo. Inhibition of cyclin E activity in cyclin E-amplified trastuzumab resistant clones, either by knockdown of cyclin E expression or treatment with cyclin-dependent kinase 2 (CDK2) inhibitors, led to a dramatic decrease in proliferation and enhanced apoptosis. In vivo, CDK2 inhibition significantly reduced tumor growth of trastuzumab-resistant xenografts. Our findings point to a causative role for cyclin E overexpression and the consequent increase in CDK2 activity in trastuzumab resistance and suggest that treatment with CDK2 inhibitors may be a valid strategy in patients with breast tumors with HER2 and cyclin E coamplification/overexpression. 相似文献
867.
868.
M Julio-Pieper NP Hyland JA Bravo TG Dinan JF Cryan 《British journal of pharmacology》2010,160(2):367-375
Background and purpose:
Increasing evidence implicates metabotropic glutamate receptor mGlu7 in the pathophysiology of stress-related disorders such as depression and anxiety. Mood disorders are frequently associated with gastrointestinal (GI) dysfunction; however, the role of mGlu7 receptors outside the CNS is unknown. This present study investigated the expression and possible functional role of mGlu7 receptors in the mouse colon.Experimental approach:
Expression of mGlu7 receptor mRNA and protein was studied in mouse colon by in situ hybridization and Western blotting. Effects of the selective mGlu7 receptor agonist AMN082 on defecation and faecal parameters were studied in an isolation-induced stress model. AMN082 effects on ion transport and neuronal intracellular signalling were examined via Ussing chambers and calcium imaging.Key results:
mGlu7 receptor mRNA and protein were highly expressed in colon mucosa. Stress-induced faecal output was unaffected by AMN082, although faecal water content was increased. In mucosa/submucosa preparations, 100 nM and 1 µM AMN082 increased bethanechol-induced changes in short-circuit current in the Ussing chamber. This was sensitive to tetrodotoxin. Also, 100 nM AMN082 significantly increased calcium signalling in a subset of submucosal neurons.Conclusions and implications:
Activating mGlu7 receptors increased colonic secretory function in vivo and ex vivo. In a group of submucosal neurons, AMN082 strongly induced calcium signalling and the presence of submucosal nerves was required for the AMN082-dependent increase in secretion. These data suggest that targeting mGlu7 receptors may be useful in the treatment of central components of stress disorders and also stress-associated GI dysfunction such as diarrhoea or constipation. 相似文献869.
870.